4.4 Article

Osteoporosis treatment in Austria-assessment of FRAX-based intervention thresholds for high and very high fracture risk

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Endocrinology & Metabolism

Osteoporosis in Europe: a compendium of country-specific reports

Carl Willers et al.

Summary: This report describes the epidemiology, burden, and treatment of osteoporosis in the European Union countries, Switzerland, and the UK. It highlights the high clinical and economic burden of osteoporotic fractures and the significant treatment gap. However, there has been a decrease in the use of pharmacological prevention for osteoporosis in recent years, indicating a need for a change in healthcare policy.

ARCHIVES OF OSTEOPOROSIS (2022)

Article Endocrinology & Metabolism

Thirty years of hip fracture incidence in Austria: is the worst over?

Hans Peter Dimai et al.

Summary: Nationwide hip fracture incidence in the Austrian population was assessed over a 30-year period, showing an increase in absolute numbers for men but a decrease in women and age-standardized incidences for both genders. Despite a slight decrease in absolute numbers of hip fractures in women over the last 10 years, the trend of decreasing age-standardized incidences in both men and women may indicate a positive direction. However, the rapid aging of the population could potentially compromise this trend in the future.

OSTEOPOROSIS INTERNATIONAL (2022)

Article Endocrinology & Metabolism

UK clinical guideline for the prevention and treatment of osteoporosis

Celia L. Gregson et al.

Summary: The National Osteoporosis Guideline Group (NOGG) has revised the UK guideline for the assessment and management of osteoporosis and the prevention of fragility fractures in postmenopausal women and older men. This comprehensive guideline provides recommendations based on systematic reviews, meta-analyses, and randomized controlled trials. It has been accredited by NICE and endorsed by international organizations.

ARCHIVES OF OSTEOPOROSIS (2022)

Review Geriatrics & Gerontology

Management of patients at very high risk of osteoporotic fractures through sequential treatments

Elizabeth M. Curtis et al.

Summary: Osteoporosis care has evolved significantly, with established clinical definitions, validated fracture risk assessment methods, and effective pharmacological agents. Anabolic agents have shown to be more rapid and efficacious in reducing fracture risk compared to antiresorptive therapies. Expert recommendations support an initial intervention with anabolic agents for high-risk fracture patients, followed by maintenance therapy using antiresorptive agents and long-term osteoporosis treatment.

AGING CLINICAL AND EXPERIMENTAL RESEARCH (2022)

Article Endocrinology & Metabolism

Mind the gap: Incidence of osteoporosis treatment after an osteoporotic fracture - results of the Austrian branch of the International Costs and Utilities Related to Osteoporotic Fractures Study (ICUROS)

O. Malle et al.

Summary: This study evaluated the treatment rate after a major osteoporotic fracture (MOF) in Austria, finding that the majority of patients did not receive osteoporosis treatment at the time of fracture. The low treatment rate indicates a need for better secondary fracture prevention measures to be implemented.
Article Endocrinology & Metabolism

A novel economic framework to assess the cost-effectiveness of bone-forming agents in the prevention of fractures in patients with osteoporosis

E. Soreskog et al.

Summary: A cost-effectiveness model was developed to evaluate sequential osteoporosis therapies and the elevated fracture risk associated with a recent fracture, showing that using a bone-forming agent followed by an antiresorptive therapy may be cost-effective. Including these technical attributes in economic evaluations can provide support for decision-making on policy and reimbursement.

OSTEOPOROSIS INTERNATIONAL (2021)

Article Endocrinology & Metabolism

An assessment of intervention thresholds for very high fracture risk applied to the NOGG guidelines A report for the National Osteoporosis Guideline Group (NOGG)

J. A. Kanis et al.

Summary: The study developed intervention thresholds based on the hybrid assessment model of NOGG, finding that 56% of women age 50 years or more would be characterized at very high risk using the upper intervention threshold with IOF/ESCEO criteria. Most trial participants exposed to romosozumab or teriparatide would fall into the very high-risk category.

OSTEOPOROSIS INTERNATIONAL (2021)

Review Geriatrics & Gerontology

Role of bone-forming agents in the management of osteoporosis

Michael R. McClung

Summary: Recent evidence supports the use of osteoanabolic therapy over anti-remodeling drugs for improving bone density and reducing fracture risk rapidly, especially in high-risk patients. This review discusses the latest research findings and the current status of osteoanabolic therapy for osteoporosis.

AGING CLINICAL AND EXPERIMENTAL RESEARCH (2021)

Article Endocrinology & Metabolism

Algorithm for the management of patients at low, high and very high risk of osteoporotic fractures

J. A. Kanis et al.

OSTEOPOROSIS INTERNATIONAL (2020)

Article Endocrinology & Metabolism

European guidance for the diagnosis and management of osteoporosis in postmenopausal women

J. A. Kanis et al.

OSTEOPOROSIS INTERNATIONAL (2019)

Article Endocrinology & Metabolism

Persistence of Excess Mortality Following Individual Nonhip Fractures: A Relative Survival Analysis

Thach Tran et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2018)

Article Endocrinology & Metabolism

Imminent risk of fracture after fracture

H. Johansson et al.

OSTEOPOROSIS INTERNATIONAL (2017)

Article Endocrinology & Metabolism

A framework for the development of guidelines for the management of glucocorticoid-induced osteoporosis

S. Lekamwasam et al.

OSTEOPOROSIS INTERNATIONAL (2012)

Review Endocrinology & Metabolism

A systematic review of hip fracture incidence and probability of fracture worldwide

J. A. Kanis et al.

OSTEOPOROSIS INTERNATIONAL (2012)

Article Health Care Sciences & Services

Which fractures are most attributable to osteoporosis?

Amy H. Warriner et al.

JOURNAL OF CLINICAL EPIDEMIOLOGY (2011)

Article Endocrinology & Metabolism

The potential impact of new National Osteoporosis Foundation guidance on treatment patterns

B. Dawson-Hughes et al.

OSTEOPOROSIS INTERNATIONAL (2010)

Editorial Material Endocrinology & Metabolism

The cost-effectiveness of alendronate in the management of osteoporosis

John A. Kanis et al.

Article Endocrinology & Metabolism

Case finding for the management of osteoporosis with FRAX® -: assessment and intervention thresholds for the UK

J. A. Kanis et al.

OSTEOPOROSIS INTERNATIONAL (2008)

Article Endocrinology & Metabolism

Epidemiology of osteoporotic fractures

Olof Johnell et al.

OSTEOPOROSIS INTERNATIONAL (2005)

Article Endocrinology & Metabolism

Optimization of BMD measurements to identify high risk groups for treatment - A test analysis

H Johansson et al.

JOURNAL OF BONE AND MINERAL RESEARCH (2004)

Article Endocrinology & Metabolism

Standardization of bone mineral density at femoral neck, trochanter and Ward's triangle

Y Lu et al.

OSTEOPOROSIS INTERNATIONAL (2001)